ANVS
#4203
Annovis Bio, Inc. Common Stock
1.0 7 USD
-0.06%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-6.14%
Variación mensual
-3.60%
Variación en los últimos 6 meses
-37.43%
Cambio anual
-34.76%
Cierres anteriores
1.1 4
Open
1.1 5
Mínimo
1.0 6
Máximo
1.1 5
Financials
- Market Capitalization 45.59 M
- Employee 7
- Founded 2008
- CEO Maria-luisa Maccecchini
- Website www.annovisbio.com
- Headquarter Delaware, United States
- FIGI BBG00PN9XD40
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4194 |  APLM Apollomics Inc. - Class A Ordinary Shares | 21.17 USD | -1.53% | -6.99% | -8.67% | +15.05% | 46.49 M USD | ||
| 4195 |  CELU Celularity Inc. - Class A Common Stock | 1.43 USD | -2.72% | -16.37% | +8.33% | -28.86% | 46.40 M USD | ||
| 4228 |  TIL Instil Bio, Inc. - Common Stock | 6.31 USD | -4.10% | -9.73% | -14.27% | -67.62% | 42.79 M USD | ||
| 4236 |  TVGN Tevogen Bio Holdings Inc. - Common Stock | 6.50 USD | -2.69% | -0.31% | -8.71% | +815.49% | 42.33 M USD |